Mon05292017

Get-Treatment_now

Club Drug Trends

Club Drug Trends and Statistics in 1996 show that the problem is far from being gone.

The club drug Gamma-hydroxybutyrate (GHB) shows increasing trends in poison control cases in Boston, Miami, and Texas, and is suspected in deaths in Miami; it is also part of the club scene (but not reported as a significant problem) in Baltimore, Honolulu, New York City, and areas of New Jersey; in Atlanta, it has become common as a synthetic steroid. Another club drug, ketamine ("Special K" or "Vitamin K"), shows increasing club drug trends of availability in Boston (where youth both smoke and inject it), Honolulu, Miami, Minneapolis/St. Paul (where adolescents and young adults snort ketamine and sometimes sprinkle it on tobacco or marijuana), New York City (where recent legislation has classified it as a controlled substance), and Washington, DC.

The club drug Flunetrazepam (Rohypnol) shows a sharply curtailed trend in Miami since State and Federal legislative measures were enacted. In Texas, however, it continues to be reported by treatment admissions, especially youth, in border areas. It continues to be reported in "date rape" incidents in Atlanta, Minnesota (where large quantities of Rohypnol have been seized), and the Washington, DC area; and it is used as a club drug in Atlanta and Honolulu. It has received media attention in some cities, such as San Diego and Seattle, but is not a widespread problem there.

Clonazepam (marketed as Klonopin in the United States and Rivotril in Mexico), is sold and abused as flunetrazepam in Miami; on the Texas-Mexico border, juveniles widely use it in combination with alcohol, specifically beer, just as they had used flunetrazepam before the import ban. Opiate addicts use it to enhance the effects of methadone in Atlanta, Boston, and Minneapolis/St. Paul (where availability has declined).

These club drugs continue to be a problem in all areas in the United States.  The club drug trends clearly show that the problem is far from minimizing.

Information released by the National Institute on Drug Abuse

footer